[1]
2021. Use of liraglutide in the medicinal therapeutic approach of non-alcoholic steatohepatitis (NASH). Research, Society and Development. 10, 10 (Aug. 2021), e389101018921. DOI:https://doi.org/10.33448/rsd-v10i10.18921.